These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11704870

  • 41. Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer.
    Klebig C, Seitz S, Arnold W, Deutschmann N, Pacyna-Gengelbach M, Scherneck S, Petersen I.
    Cancer Res; 2005 Jan 15; 65(2):394-400. PubMed ID: 15695379
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Identification of the A kinase anchor protein 12 (AKAP12) gene as a candidate tumor suppressor of hepatocellular carcinoma.
    Hayashi M, Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S, Kodera Y.
    J Surg Oncol; 2012 Mar 15; 105(4):381-6. PubMed ID: 22052684
    [Abstract] [Full Text] [Related]

  • 45. Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells.
    Matsuda K, Maruyama H, Guo F, Kleeff J, Itakura J, Matsumoto Y, Lander AD, Korc M.
    Cancer Res; 2001 Jul 15; 61(14):5562-9. PubMed ID: 11454708
    [Abstract] [Full Text] [Related]

  • 46. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P, Schirmacher P, Lorenzo Bermejo J, Longerich T.
    Hepatology; 2012 Nov 15; 56(5):1817-27. PubMed ID: 22689435
    [Abstract] [Full Text] [Related]

  • 47. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
    Hartsough MT, Clare SE, Mair M, Elkahloun AG, Sgroi D, Osborne CK, Clark G, Steeg PS.
    Cancer Res; 2001 Mar 01; 61(5):2320-7. PubMed ID: 11280805
    [Abstract] [Full Text] [Related]

  • 48. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
    Shao G, Berenguer J, Borczuk AC, Powell CA, Hei TK, Zhao Y.
    Cancer Res; 2006 May 01; 66(9):4566-73. PubMed ID: 16651406
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.
    Mol Cancer; 2008 Nov 06; 7():83. PubMed ID: 18990230
    [Abstract] [Full Text] [Related]

  • 51. Glypican-3 (GPC3) expression in human placenta: localization to the differentiated syncytiotrophoblast.
    Khan S, Blackburn M, Mao DL, Huber R, Schlessinger D, Fant M.
    Histol Histopathol; 2001 Jan 06; 16(1):71-8. PubMed ID: 11193214
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Modulation of the connexin26 tumor suppressor gene expression through methylation in human mammary epithelial cell lines.
    Singal R, Tu ZJ, Vanwert JM, Ginder GD, Kiang DT.
    Anticancer Res; 2000 Jan 06; 20(1A):59-64. PubMed ID: 10769635
    [Abstract] [Full Text] [Related]

  • 55. High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer.
    Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, Sukumar S.
    Proc Natl Acad Sci U S A; 2000 May 23; 97(11):6049-54. PubMed ID: 10811911
    [Abstract] [Full Text] [Related]

  • 56. Discovery and diagnostic value of a novel oncofetal protein: glypican 3.
    Wang SK, Zynger DL, Hes O, Yang XJ.
    Adv Anat Pathol; 2014 Nov 23; 21(6):450-60. PubMed ID: 25299314
    [Abstract] [Full Text] [Related]

  • 57. Genotype/phenotype correlations of males affected by Simpson-Golabi-Behmel syndrome with GPC3 gene mutations: patient report and review of the literature.
    Mariani S, Iughetti L, Bertorelli R, Coviello D, Pellegrini M, Forabosco A, Bernasconi S.
    J Pediatr Endocrinol Metab; 2003 Feb 23; 16(2):225-32. PubMed ID: 12713262
    [Abstract] [Full Text] [Related]

  • 58. Glypican-3 is overexpressed in human hepatocellular carcinoma.
    Sung YK, Hwang SY, Park MK, Farooq M, Han IS, Bae HI, Kim JC, Kim M.
    Cancer Sci; 2003 Mar 23; 94(3):259-62. PubMed ID: 12824919
    [Abstract] [Full Text] [Related]

  • 59. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).
    Hu H, Li S, Cui X, Lv X, Jiao Y, Yu F, Yao H, Song E, Chen Y, Wang M, Lin L.
    J Biol Chem; 2013 Apr 19; 288(16):10973-85. PubMed ID: 23436656
    [Abstract] [Full Text] [Related]

  • 60. Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome.
    Lindsay S, Ireland M, O'Brien O, Clayton-Smith J, Hurst JA, Mann J, Cole T, Sampson J, Slaney S, Schlessinger D, Burn J, Pilia G.
    J Med Genet; 1997 Jun 19; 34(6):480-3. PubMed ID: 9192268
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.